Related Experiment Video
Updated: Apr 22, 2026

07:23
Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
34.7K
Modelling concentration-analgesia relationships for morphine to evaluate experimental pain models
Eva Sverrisdóttir1, David John Richard Foster2, Richard Neil Upton2
1Department of Drug Design and Pharmacology, Faculty of Health Sciences, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark.
Summary
Muscle pressure pain models are better for assessing morphine
Area of Science:
- Pharmacology
- Pain Management
- Clinical Pharmacology
Background:
- Morphine is a potent analgesic used for pain management.
- Developing accurate models to assess drug efficacy is crucial.
- Experimental pain models help evaluate analgesic effects.
Purpose of the Study:
- To create population pharmacokinetic-pharmacodynamic (PK-PD) models for morphine.
- To assess experimental pain models for evaluating morphine's analgesic effects.
- To compare muscle pressure and skin heat pain models for morphine assessment.
Main Methods:
- Randomized, double-blind, placebo-controlled, crossover study.
- Involved 39 healthy volunteers receiving oral morphine or placebo.
- Utilized non-linear mixed-effects modeling for PK-PD analysis.
Main Results:
- Developed PK-PD models for morphine in skin heat and muscle pressure pain.
- Morphine's analgesic effect was proportional to baseline pain.
- A steady-state concentration of 21ng/ml morphine increased muscle pressure stimulus intensity by 33% and skin heat by 0.84%.
Conclusions:
- Muscle pressure pain models are more clinically relevant for assessing morphine pharmacodynamics than skin heat models.
- The developed PK-PD models provide insights into morphine's dose-response relationship.
- Individual variability in pain response and drug effect was successfully modeled.
More Related Videos
Related Concept Videos
Analgesia and Pain Management
3.1K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
3.1K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.5K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners
1.6K
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
1.6K
Opioid Receptors: Overview
6.9K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
6.9K

